SaumilRajshekharOzaMD

Adult Congenital Heart Disease, Cardiac Electrophysiology

Chief, Division of Cardiology St. Vincents Medical Center-Riverside; Co-Director, The Atrial Fibrillation Institute; Clinical Cardiac Electrophysiologist

Join to view full profile

Dr. Oza is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Oza's full profile

Already have an account?

Office
1824 King St
Suite 300
Jacksonville, FL 32204
Phone+1 904-388-1820

Fax+1 904-388-1827

Education & Training

Loyola University Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2007 - 2008
Loyola University Medical CenterFellowship, Cardiovascular Disease, 2004 - 2007
University of Illinois College of Medicine at ChicagoResidency, Internal Medicine, 2001 - 2004
University of Miami Leonard M. Miller School of MedicineClass of 2001

Certifications & Licensure

FL State Medical License 2008 - 2026
GA State Medical License 2010 - 2025
IL State Medical License 2001 - 2008
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Clinical Cardiac Electrophysiology

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study Start of enrollment: 2012 Apr 01
Completed
CARTO® 3 System and Real Time Intracardiac Ultrasound Start of enrollment: 2012 Oct 01
Completed
nMARQ™ Pulmonary Vein Isolation System for the Treatment of Paroxysmal Atrial Fibrillation Start of enrollment: 2013 Apr 01
Terminated
Phase 3
CONVERGE - Epi/Endo Ablation For Treatment of Persistent Atrial Fibrillation(AF) Start of enrollment: 2013 Dec 01
Completed
Not Applicable
aMAZE Study: LAA Ligation Adjunctive to PVI for Persistent or Longstanding Persistent Atrial Fibrillation Start of enrollment: 2015 Sep 01
Active, not recruiting
Not Applicable
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients Start of enrollment: 2018 Jan 17
Active, not recruiting
Not Applicable
WAveCrest Vs. Watchman TranssEptal LAA Closure to REduce AF-Mediated STroke 2 Start of enrollment: 2017 Dec 27
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

31 citations
Very High-Power Short-Duration, Temperature-Controlled Radiofrequency Ablation in Paroxysmal Atrial Fibrillation: The Prospective Multicenter Q-FFICIENCY Trial.
Jose Osorio, Ayman A Hussein, M Craig Delaughter, George Monir, Andrea Natale
JACC. Clinical Electrophysiology. 2023-04-01
122 citations
Hybrid Convergent Procedure for the Treatment of Persistent and Long Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial.
David B. DeLurgio, Karl J. Crossen, Jaswinder Gill, Christopher Blauth, Saumil Oza
Circulation. Arrhythmia and Electrophysiology. 2020-11-13
9 citations
Healthcare Utilization and Quality of Life Improvement after Ablation for Paroxysmal AF in Younger and Older Patients.
Angelo B. Biviano, Tina D Hunter, Gopi Dandamudi, Robert S. Fishel, Brett Gidney
Pacing and Clinical Electrophysiology. 2017-04-01

Press Mentions

‘It’s Life-Changing’: Ascension St. Vincent’s Using New Tech to Treat Atrial Fibrillation PatientsAugust 11th, 2024
Procedure To Treat AFib Gaining Popularity in Jacksonville and BeyondMay 7th, 2023
TikTok ‘Dry Scooping’ Trend Is Dangerous, Experts Say — and an Awful Idea. Here’s WhyJune 15th, 2021
Join now to see all